About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Signs Japanese License Option Agreement and R&D Alliance

April 29, 2016

click here to read more

Post navigation

2015 Annual Report

Phosphagenics Signs Japanese License Option Agreement for TPM Oxycodone Patch

Related Posts

Retirement of Non-Executive Director

May 28, 2018

Phosphagenics TPM Improves Negative Effects of Heat Stress in Poultry

December 15, 2017

Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan

January 31, 2017

Recent Posts

Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025
MEDIA | Ausbiz
March 7, 2025
MEDIA | Stockhead
March 7, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.